Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alto Neuroscience, Inc. (ANRO) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alto Neuroscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1999480.
Total stock buying since 2024: $640,227.
Total stock sales since 2024: $0.
Total stock option exercises since 2024: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 42,838 | $640,227 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-07 | 15,000 | $193,712 | 0 | $0 | 0 | $0 |
| 2024-03 | 6,150 | $99,507 | 0 | $0 | 0 | $0 |
| 2024-02 | 21,688 | $347,008 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-10 | Savitz Adam (CHIEF MEDICAL OFFICER) | Buy | 2,931 | 13.22 | 38,747 |
| 2024-07-09 | Savitz Adam (CHIEF MEDICAL OFFICER) | Buy | 12,069 | 12.84 | 154,965 |
| 2024-03-28 | Smith Nicholas Conrad (CHIEF FINANCIAL OFFICER) | Buy | 6,150 | 16.18 | 99,507 |
| 2024-02-06 | Smith Nicholas Conrad (CHIEF FINANCIAL OFFICER) | Buy | 1,563 | 16.00 | 25,008 |
| 2024-02-06 | Savitz Adam (CHIEF MEDICAL OFFICER) | Buy | 17,000 | 16.00 | 272,000 |
| 2024-02-06 | Etkin Amit (PRESIDENT AND CEO) | Buy | 3,125 | 16.00 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ANRO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alto Neuroscience, Inc. (symbol ANRO, CIK number 1999480) see the Securities and Exchange Commission (SEC) website.